Baby Steps
December 13, 2018 Pediatrician Dr. Jeffrey Perlman has spearheaded simple, low-cost efforts to save newborns in Tanzania—with dramatic results.
The Bottom Line
December 11, 2018 By now, many people are familiar with the grim statistic that opioid overdoses are killing more...
Men on a Mission
December 6, 2018 When longtime research collaborators Dr. Douglas Nixon and Dr. Brad Jones arrived at Weill Cornell Medicine last summer, they brought with them an ambitious goal: to find a cure for HIV.
High Body Fat Increases Breast Cancer Risk for Women with Normal BMI
December 6, 2018 Postmenopausal women with higher levels of body fat have a significantly increased risk of developing breast cancer even if they have a normal body mass index (BMI), according to a new study.
Battling Burnout
December 5, 2018 Reflecting a national movement, Weill Cornell Medicine puts increased focus on student and physician wellness.
Study Reveals New Role for Methotrexate in Fighting Cancer
November 29, 2018 A study of the dual pathways that process the essential vitamin folate by Weill Cornell Medicine investigators unexpectedly revealed a new way the cancer drug methotrexate works and may suggest strategies to boost its cancer-killing effects.
Awards and Honors Across Weill Cornell Medicine
November 29, 2018 Awards, honors, prizes and achievements for the month of November.
Dr. Said Ibrahim Named Inaugural Senior Associate Dean for Diversity and Inclusion
November 29, 2018 Dr. Said Ibrahim has been appointed the inaugural senior associate dean for diversity and inclusion at Weill Cornell Medicine.
Sensing of Fungi by Gut Immune Cells Can Contribute to Airway Allergic Diseases
November 29, 2018 Common drug treatments that lead to changes in gut fungi can persistently exacerbate allergic airway diseases such as asthma.
Weill Cornell Medicine Awarded $9 Million Prestigious Grant for Mantle Cell Lymphoma Research
November 26, 2018 Weill Cornell Medicine has been awarded a five-year, $9 million Program Project Grant (P01) from the National Cancer Institute (NCI) to better understand how and why patients with an aggressive and incurable form of lymphoma initially respond to treatment, only to relapse over time. 

Calendar of Events